DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets has announced the addition of the "Global Lysosomal Storage Diseases Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Lysosomal Storage Diseases Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Lysosomal Storage Diseases market. It covers active Lysosomal Storage Diseases pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Lysosomal Storage Diseases - Disease Overview
2. Lysosomal Storage Diseases Pipeline Overview
3. Lysosomal Storage Diseases Phase 3 Clinical Trial Pipeline Insights
4. Lysosomal Storage Diseases Phase 2 Clinical Trial Pipeline Insights
5. Lysosomal Storage Diseases Phase 1 Clinical Trial Pipeline Insights
6. Lysosomal Storage Diseases Preclinical Research Pipeline Insights
7. Lysosomal Storage Diseases Discovery Stage Pipeline Insights
8. Lysosomal Storage Diseases Drug Development Activities - Geographic Landscape
8.1. Lysosomal Storage Diseases R&D Activities in North America
8.2. Lysosomal Storage Diseases R&D Activities in Europe
9. Lysosomal Storage Diseases Pipeline - Licensing Activities
Table 1. Lysosomal Storage Diseases Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Lysosomal Storage Diseases Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Lysosomal Storage Diseases Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Lysosomal Storage Diseases Pipeline Molecules - Preclinical Research
Table 5. Lysosomal Storage Diseases Pipeline Molecules - Drug Discovery
Table 6. Lysosomal Storage Diseases R&D Activities by Geography
Table 7. Lysosomal Storage Diseases Pipeline Molecules - North America
Table 8. Lysosomal Storage Diseases Pipeline Molecules - Europe
Table 9. Lysosomal Storage Diseases Pipeline - Licensing Activities
Figure 1. Lysosomal Storage Diseases Pipeline Molecules by R&D Stage
Figure 2. Lysosomal Storage Diseases R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/l2hjm8/global_lysosomal